Main content

Autorità Garante della Concorrenza e del Mercato

ryanairps10972

ANTICANCER DRUG PRICES REDUCED BY UP TO 80%, ANTITRUST INVESTIGATES COMPLIANCE BY ASPEN

As a result of the Authority’s investigation, the prices of some anticancer drugs distributed in Italy by Aspen decreased by as much as 82%.

On 29 September 2016, the Authority found that some companies of the Aspen Group (Aspen Pharma Trading Ltd., Aspen Italia s.r.l., Aspen Pharma Ireland Ltd., Aspen Pharmacare Holdings Ltd.) abused their dominant position by pressuring AIFA, the pharmaceutical regulator, into accepting excessively high prices for the following anticancer drugs: Leukeran (2 mg - 25 tablets), Alkeran (50 mg/10 mg powder and solvent for injectable solution - 1 bottle), Alkeran (2 mg - 25 tablets), Purinethol (50 mg - 25 tablets), Tioguanine (40 mg - 25 tablets).

read more... )